NewsCorporate ActionsKapil Cotex Limited Shareholders Approve Name Change to Skybiotech Healthcare Limited and Other Key ResolutionsKapil Cotex Limited Shareholders Approve Name Change to Skybiotech Healthcare Limited and Other Key Resolutions
Kapil Cotex Limited held its 42nd AGM on September 25, 2025, where shareholders approved nine resolutions with 99.99% approval. Key resolutions included adopting financial statements, reappointing directors, changing the company name to Skybiotech Healthcare Limited, altering the main object clause, increasing authorized share capital, and ratifying the acquisition of Skybiotech Life Sciences Private Limited shares. The approvals signal a strategic shift towards the healthcare or biotechnology sector.
*this image is generated using AI for illustrative purposes only.
Kapil Cotex Limited , soon to be known as Skybiotech Healthcare Limited, held its 42nd Annual General Meeting (AGM) on September 25, 2025, marking a significant turning point for the company. Shareholders overwhelmingly approved nine resolutions, each receiving 99.99% approval from the 1,340,695 votes cast.
Key Resolutions Passed
Financial Statements Adoption: Shareholders approved the audited financial statements for the year ended March 31, 2025, including both standalone and consolidated accounts.
Director Reappointment: Mrs. Poonam Prakash Rathi was re-appointed as a director of the company.
Secretarial Auditor Appointment: M/s. SM Dhumal & Associates were appointed as the company's Secretarial Auditors.
Independent Director Appointment: Mr. Vijay Sitaram Chitlange was appointed as a Non-Executive Independent Director.
Main Object Clause Alteration: The company's Memorandum of Association saw an alteration in its main object clause, signaling a potential shift in business focus.
Company Name Change: Shareholders approved changing the company name from Kapil Cotex Limited to Skybiotech Healthcare Limited, reflecting a new direction for the firm.
Authorized Share Capital Increase: The company received approval to increase its authorized share capital, potentially paving the way for future growth and expansion.
Ratification of Share Acquisition: Shareholders ratified the acquisition of equity shares in Skybiotech Life Sciences Private Limited, which had exceeded limits under section 186(2) of the Companies Act, 2013.
Voting Details
The voting process included both remote e-voting and polling at the AGM. The results showed strong shareholder support across all resolutions:
| Category | Votes Polled | Votes in Favor | Votes Against | % in Favor |
|---|---|---|---|---|
| Promoter and Promoter Group | 1,215,575 | 1,215,575 | 0 | 100.00% |
| Public - Non Institutions | 125,120 | 125,111 | 9 | 99.99% |
| Total | 1,340,695 | 1,340,686 | 9 | 99.99% |
Looking Ahead
The approval of these resolutions, particularly the name change and alteration of the main object clause, suggests a strategic shift for the company. The move from Kapil Cotex Limited to Skybiotech Healthcare Limited indicates a potential pivot towards the healthcare or biotechnology sector, which could open up new opportunities for growth and diversification.
The increase in authorized share capital and the ratification of the acquisition of Skybiotech Life Sciences Private Limited shares further underscore the company's ambitious plans for expansion and development in its new direction.
As Kapil Cotex embarks on this new chapter, stakeholders will be keen to observe how these changes translate into operational and financial performance in the coming years.
Historical Stock Returns for Kapil Cotex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.01% | -12.43% | -25.26% | -20.86% | -44.45% | +654.02% |
15
